Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres

Boussaud, V.; Guillemain, R.; Grenet, D.; Coley, N.; Souilamas, R.; Bonnette, P.; Stern, M.
August 2008
Thorax;Aug2008, Vol. 63 Issue 8, p732
Academic Journal
Background: Infection with Burkholderia cepacia complex (BCC) is a life threatening complication of cystic fibrosis (CF), often seen as a contraindication for lung transplantation. Methods: A long term retrospective study was conducted of all patients with CF undergoing lung transplants from January 1990 to October 2006 in two French centres allowing transplantation in patients colonised with BCC. Results: 22 of the 247 lung transplant patients with CF were infected with BCC (B cenocepacia genomovar Ill (n = 8), B multivorans genomovar II (n = 11), B vietnamiensis genomovar V (n = 2) and B stab//is genomovar IV (n = 1)). BCC colonisation was not associated with any significant excess mortality (HR 1.5, 95% Cl 0.7 to 3.2; p = 0.58). However, early mortality rates tended to be higher in the BCC group than in the non-BCC group (3 month survival: 85% vs 95%, respectively; log rank p = 0.05). Univariate analysis showed that the risk of death was significantly higher for the eight patients infected with B cenocepacia than for the other 14 colonised patients (HR 3.2, 95% Cl 1.1 to 5.9; p = 0.04). None of the other risk factors tested—primary graft failure, late extubation, septicaemia—had a significant effect. The 5 year cumulative incidence rate of bronchiolitis obliterans syndrome was not significantly higher in the BCC group than in the non-BCC group (38% vs 24%, respectively; p = 0.35). Conclusion: Our results suggest that BCC infection with a non-genomovar Ill organism may not be associated with excess mortality after lung transplantation in patients with CF and should not be seen as sufficient reason to exclude lung transplantation. However, colonisation with B cenocepacia remains potentially detrimental.


Related Articles

  • Cystic fibrosis: lung transplantation. A new option -- a new dilemma! Wells, F.; Caine, N.; Sharples, L.; Wallwork, J. // Journal of the Royal Society of Medicine (Supplement);Jan1992, Vol. 85 Issue 19, p9 

    The article discusses the dilemma in conducting heart and lung transplantation (HLT) on patients with cystic fibrosis who have developed chronic pulmonary infection. It cites the results of HLT technique applied to patients with CF. It explains the procedures involved in double sequential single...

  • Lung transplantation in adolescents and young adults with cystic fibrosis. Yorke, Janelle; Parle, Michael; James, Melveta; Gay, Tatiana; Harkess, Michelle; Glanville, Allan // Progress in Transplantation;Dec2006, Vol. 16 Issue 4, p343 

    Context--Little is known about adolescents' and young adults' experience with cystic fibrosis while waiting for or after receiving a lung transplant. The psychological and psychosocial factors that may influence these patients' transplant outcomes are yet to be fully explored. Objective--To...

  • Transplantation using lung lobes from living donors. Hodson, Margaret E. // Journal of Medical Ethics;Dec2000, Vol. 26 Issue 6, p419 

    Discusses the importance of lung lobe donation to patients suffering from cystic fibrosis (CF). Survival rate of CF patients who undergone lung lobe transplant; How a living lung lobe transplant should be arranged; Ethical dilemmas of lung lobe transplant.

  • Fatal Outcome of Lung Transplantation in Cystic Fibrosis Patients due to Small-Colony Variants of the Burkholderia cepacia Complex. Hä;uβler, S.; Lehmann, C.; Breselge, C.; Rohde, M.; Claβen, M.; Tümmler, B.; Vandamme, P.; Steinmetz, I. // European Journal of Clinical Microbiology & Infectious Diseases;Apr2003, Vol. 22 Issue 4, p249 

    The aim of this study was to investigate the possible role of small-colony variant morphotypes of Burkholderia cepacia-like organisms in infectious complications in cystic fibrosis patients following lung transplantation. Respiratory tract specimens from 470 cystic fibrosis patients were...

  • Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Meachery, G.; De Soyza, A.; Nicholson, A.; Parry, G.; Hasan, A.; Tocewicz, K.; Piliay, I.; Clark, S.; Lordan, J. L.; Schueler, S.; Fisher, A. J.; Dark, J. H.; Gould, F. K.; Corns, P. A.; Pillay, T; Corris, P A // Thorax;Aug2008, Vol. 63 Issue 8, p725 

    Background: Lung transplantation is an important option to treat patients with advanced cystic fibrosis (CF) lung disease. The outcomes of a large UK cohort of CF lung transplantation recipients is reported. Methods: Retrospective review of case notes and...

  • Does Lung Transplantation Provide Good Outcomes in Cystic Fibrosis Patients? Edmond, Lissa // Pulmonary Reviews;Sep2008, Vol. 13 Issue 9, p14 

    The article discusses the outcome of lung transplantation in Cystic Fibrosis (CF) patients. It states that among the 176 lung transplantation done in CF group 40% had diabetes mellitus prior to the transplantation and 20% developed diabetes after the transplantation. Veronique Boussaud, MD, from...

  • Aspergillus infection in lung transplant patients: incidence and prognosis. Iversen, M.; Burton, C. M.; Vand, S.; Skovfoged, L.; Carlsen, J.; Milman, N.; Andersen, C. B.; Rasmussen, M.; Tvede, M. // European Journal of Clinical Microbiology & Infectious Diseases;Dec2007, Vol. 26 Issue 12, p879 

    Lung transplant recipients experience a particularly high incidence of Aspergillus infection in comparison with other solid-organ transplantations. This study was conducted to determine the incidence of Aspergillus colonisation and invasive aspergillosis, and the impact on long-term survival...

  • Development of a decision aid for adult cystic fibrosis patients considering referral for lung transplantation. Vandemheen, Katherine L.; Aaron, Shawn D.; Poirier, Charles; Tullis, Elizabeth; O'Connor, Annette // Progress in Transplantation;Mar2010, Vol. 20 Issue 1, p81 

    Context—Most adults with cystic fibrosis are eventually required to make a decision about referral for lung transplantation. Objective—To identify the decisional needs of these patients and to develop a decision aid to address these needs. Methods—A comprehensive review of...

  • Lung Transplantation for Cystic Fibrosis: Additional Considerations. Vittone, Sarah // Pediatric Nursing;Jan/Feb2001, Vol. 27 Issue 1, p90 

    Provides an overview on the actual process which children with cystic fibrosis and their families go through with the lung transplantation procedure. Details on the procedure; Significance of the involvement of the child in the decision making; Implications of the decision for transplant on the...


Read the Article


Sign out of this library

Other Topics